Craft

Yuyu Pharma

Stock Price

₩4.4 K

2024-10-29

Market Capitalization

₩72.4 B

2024-10-29

Revenue

₩137.2 B

FY, 2023

Yuyu Pharma Summary

Company Summary

Overview
Yuyu Pharma (유유제약, formerly known as YuYu) is a company that manufactures, distributes, and develops medicines. It offers prescription and over-the-counter (OTC) drugs, health-functional foods, chewable tablets, and other products. The comapny specializes in the therapeutic areas of osteoporosis, respiratory, and urology.
Type
Public
Status
Active
Founded
1941
HQ
Seoul, KR | view all locations
Website
https://www.yuyu.co.kr
Cybersecurity rating
Sectors

Key People

  • Robert Wonsang Yu

    Robert Wonsang Yu, President and CEO

  • Noel Park
  • Laxmikant Gharat, Director and Head, Business Development

LocationsView all

12 locations detected

  • Seoul, Seoul HQ

    Korea (Republic of)

    Yuyu Building, 197 Dongho-ro

  • Anyang, Gyeonggi-do

    Korea (Republic of)

    813 Gyeongsu-daero

  • Bucheon, Gyeonggi-do

    Korea (Republic of)

    54 Buil-ro 205beon-gil

  • Busan, Busan

    Korea (Republic of)

    3-7 Jungang-daero 296beon-gil

  • Changwon-si, Gyeongsangnam-do

    Korea (Republic of)

    12 Pyeongsan-ro 215beon-gil

  • Daegu, Daegu

    Korea (Republic of)

    487 Dongdaegu-ro

and 6 others

Yuyu Pharma Financials

Summary Financials

Revenue (Q3, 2025)
₩37.8B
Gross profit (Q3, 2025)
₩12.6B
Net income (Q3, 2025)
₩4.3B
Cash (Q3, 2025)
₩28.7B
EBIT (Q3, 2025)
₩2.0B
Enterprise value
$72.6B

Footer menu